How the Product Works:
Activates GIP and GLP-1 receptors to enhance insulin secretion
Slows gastric emptying, reducing appetite
Aids in weight reduction
Improves daily blood glucose control
Recommended for:
Adults with type 2 diabetes
Patients with overweight and insulin resistance
Individuals not reaching glycaemic targets with other therapies
Treatment of type 2 diabetes mellitus in adults, either as monotherapy or in combination with other medications when previous therapies are insufficient.
Administered subcutaneously once weekly. Dosage is determined individually by a healthcare provider, with gradual increases if necessary. Injection sites include the abdomen, thigh, or upper arm, with rotation recommended.
Contraindications:
Hypersensitivity to Tirzepatide
Severe renal or hepatic impairment
Type 1 diabetes
Pregnancy and lactation
Children under 18 years
Side Effects:
Nausea, vomiting
Diarrhoea or constipation
Headache
Injection site reactions
Possible hypoglycaemia when used with other antidiabetic agents
